Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Non-Hodgkin Lymphoma: early-phase trial registry
58 of 107 indexed Non-Hodgkin Lymphoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #120 of 28,707 conditions by registered trial count.
107 US clinical trials · 58 currently recruiting · #120 of 28,707 conditions by registered trial count
Non-Hodgkin Lymphoma: 107 US clinical trials tracked, 58 recruiting.
Non-Hodgkin Lymphoma is the subject of 107 registered US clinical trials on ClinicalTrials.gov, 58 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 86 in Phase 1-2 (earlier-stage). The most active sponsor is Baylor College of Medicine, running 7 of these trials.
Enrollment posture brief
Registry condition non-hodgkin-lymphoma
OPEN 58 | RECR 54% | LATE 6 | EARLY 86 | RANK #120 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Bulimia Nervosa (54% recruiting · 24 trials)
Non-Hodgkin Lymphoma lists 58 open slots (54% of 107 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Non-Hodgkin Lymphoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Non-Hodgkin Lymphoma is recruiting above its size-band peers.
58 of 107 indexed trials (54.2%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Non-Hodgkin Lymphoma trials is spread across many organizations.
Baylor College of Medicine accounts for 7 of 107 trials (6.5%). 77 distinct sponsors appear on at least one study for this condition label.
-
Most Non-Hodgkin Lymphoma trials plan to enrol fewer than 100 people.
Median target enrolment is 54 among the 107 trials that report a genuine target (sentinel values excluded). 68 of those (63.6%) plan for fewer than 100 participants.
-
Non-Hodgkin Lymphoma research is mostly interventional.
98 interventional and 9 observational studies make up this index (91.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
107 total, page 3 of 3
A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors
Novartis Pharmaceuticals
NCT00503451
Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy
H. Lee Moffitt Cancer Center and Research Institute
NCT05065866
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
Case Comprehensive Cancer Center
NCT02129582
Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
ViaCell
NCT00089596
Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)
University of Colorado, Denver
NCT04240808
Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
Kymera Therapeutics
NCT05233033
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
TCR2 Therapeutics
NCT04323657
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 67 |
| Phase 2 | 19 |
| Phase 3 | 4 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Non-Hodgkin Lymphoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Non-Hodgkin Lymphoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Non-Hodgkin Lymphoma page
107 registered trials, 58 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 58 Non-Hodgkin Lymphoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Baylor College of Medicine sponsors the most Non-Hodgkin Lymphoma trials on record, review their full trial history before evaluating a specific study. See Baylor College of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Non-Hodgkin Lymphoma condition card totals 107 registered trials; most-linked intervention Cyclophosphamide; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.